Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2
The science continued evolving
Diabetes 54 , 22122218 (2005)
Indeed, this delayed L4 GSC defect occurs in mutants raised at 15 and 20, but at 25, the effect is even further delayed with GSCs continuing to divide in adults and persisting in an undifferentiated state (MERRITT et al
Moore also believes that slower, more sustainable weight loss allows the body more time to adjust to changes in weight, reducing the side-effect profile and potentially leading to better long-term success
As healthcare professionals, the onus lies on us to stay informed about the most effective weight management solutions, including cutting-edge treatments such as Semaglutide, Tirzepatide, and other GLP-1 receptor agonists